These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 7834830

  • 1. cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells.
    Draijer R, Atsma DE, van der Laarse A, van Hinsbergh VW.
    Circ Res; 1995 Feb; 76(2):199-208. PubMed ID: 7834830
    [Abstract] [Full Text] [Related]

  • 2. Cyclic-GMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers.
    Westendorp RG, Draijer R, Meinders AE, van Hinsbergh VW.
    J Vasc Res; 1994 Feb; 31(1):42-51. PubMed ID: 7903872
    [Abstract] [Full Text] [Related]

  • 3. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin.
    Draijer R, Vaandrager AB, Nolte C, de Jonge HR, Walter U, van Hinsbergh VW.
    Circ Res; 1995 Nov; 77(5):897-905. PubMed ID: 7554143
    [Abstract] [Full Text] [Related]

  • 4. Atrial natriuretic peptide regulation of endothelial permeability is mediated by cGMP.
    Lofton CE, Newman WH, Currie MG.
    Biochem Biophys Res Commun; 1990 Oct 30; 172(2):793-9. PubMed ID: 2173580
    [Abstract] [Full Text] [Related]

  • 5. Modulation of agonist-induced calcium mobilisation in bovine aortic endothelial cells by phorbol myristate acetate and cyclic AMP but not cyclic GMP.
    Buchan KW, Martin W.
    Br J Pharmacol; 1991 Oct 30; 104(2):361-6. PubMed ID: 1665733
    [Abstract] [Full Text] [Related]

  • 6. Effects of LDL on intracellular free calcium and nitric oxide-dependent cGMP formation in porcine endothelial cells.
    Pohl U, Heydari N, Galle J.
    Atherosclerosis; 1995 Oct 30; 117(2):169-78. PubMed ID: 8801862
    [Abstract] [Full Text] [Related]

  • 7. Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2.
    Diebold I, Djordjevic T, Petry A, Hatzelmann A, Tenor H, Hess J, Görlach A.
    Circ Res; 2009 May 22; 104(10):1169-77. PubMed ID: 19390057
    [Abstract] [Full Text] [Related]

  • 8. Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP.
    Heller R, Polack T, Gräbner R, Till U.
    Atherosclerosis; 1999 May 22; 144(1):49-57. PubMed ID: 10381277
    [Abstract] [Full Text] [Related]

  • 9. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
    Chang YS, Munn LL, Hillsley MV, Dull RO, Yuan J, Lakshminarayanan S, Gardner TW, Jain RK, Tarbell JM.
    Microvasc Res; 2000 Mar 22; 59(2):265-77. PubMed ID: 10684732
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide and cGMP regulate endothelial permeability and F-actin distribution in hydrogen peroxide-treated endothelial cells.
    Liu SM, Sundqvist T.
    Exp Cell Res; 1997 Aug 25; 235(1):238-44. PubMed ID: 9281373
    [Abstract] [Full Text] [Related]

  • 11. Dual role of cGMP in modulation of macromolecule permeability of aortic endothelial cells.
    Hölschermann H, Noll T, Hempel A, Piper HM.
    Am J Physiol; 1997 Jan 25; 272(1 Pt 2):H91-8. PubMed ID: 9038926
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of ularitide acetate and other bronchorelaxing substances on the thrombin-induced permeability raise of human endothelial cell monolayers.
    Korn C, Neidlein R, Strein K, Wilhelms OH.
    Arzneimittelforschung; 1998 Mar 25; 48(3):251-8. PubMed ID: 9553682
    [Abstract] [Full Text] [Related]

  • 13. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE, Lugnier C.
    Br J Pharmacol; 1994 Oct 25; 113(2):445-50. PubMed ID: 7834194
    [Abstract] [Full Text] [Related]

  • 14. Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability.
    Suttorp N, Hippenstiel S, Fuhrmann M, Krull M, Podzuweit T.
    Am J Physiol; 1996 Mar 25; 270(3 Pt 1):C778-85. PubMed ID: 8638657
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3.
    Surapisitchat J, Jeon KI, Yan C, Beavo JA.
    Circ Res; 2007 Oct 12; 101(8):811-8. PubMed ID: 17704206
    [Abstract] [Full Text] [Related]

  • 16. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
    Moritoki H, Yoshikawa T, Hisayama T, Takeuchi S.
    Eur J Pharmacol; 1992 Jan 07; 210(1):61-8. PubMed ID: 1350988
    [Abstract] [Full Text] [Related]

  • 17. Hyperpermeability of pulmonary endothelial monolayer: protective role of phosphodiesterase isoenzymes 3 and 4.
    Suttorp N, Ehreiser P, Hippenstiel S, Fuhrmann M, Krüll M, Tenor H, Schudt C.
    Lung; 1996 Jan 07; 174(3):181-94. PubMed ID: 8830194
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide-induced microvascular permeability alterations: a regulatory role for cGMP.
    Kubes P.
    Am J Physiol; 1993 Dec 07; 265(6 Pt 2):H1909-15. PubMed ID: 8285229
    [Abstract] [Full Text] [Related]

  • 19. Role of nitric oxide and cyclic guanosine 3',5'-monophosphate in the estrogen regulation of cervical epithelial permeability.
    Gorodeski GI.
    Endocrinology; 2000 May 07; 141(5):1658-66. PubMed ID: 10803574
    [Abstract] [Full Text] [Related]

  • 20. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase.
    Arnal JF, Warin L, Michel JB.
    J Clin Invest; 1992 Aug 07; 90(2):647-52. PubMed ID: 1379615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.